Tampere University of Technology

TUTCRIS Research Portal

Multifunctional Hyaluronic Acid and Chondroitin Sulfate Nanoparticles: Impact of Glycosaminoglycan Presentation on Receptor Mediated Cellular Uptake and Immune Activation

Research output: Contribution to journalArticleScientificpeer-review

Details

Original languageEnglish
Pages (from-to)20614-20624
Number of pages11
JournalACS Applied Materials and Interfaces
Volume8
Issue number32
DOIs
Publication statusPublished - 17 Aug 2016
Publication typeA1 Journal article-refereed

Abstract

Hyaluronic acid (HA) and chondroitin sulfate (CS) polymers are extensively used for various biomedical applications, such as for tissue engineering, drug delivery, and gene delivery. Although both these biopolymers are known to target cell surface CD44 receptors, their relative cellular targeting properties and immune activation potential have never been evaluated. In this article, we present the synthesis and characterization of novel self assembled supramolecular HA and CS nanoparticles (NPs). These NPs were developed using fluorescein as a hydrophobic component that induced amphiphilicity in biopolymers and also efficiently stabilized anticancer drug doxorubicin (DOX) promoting a near zero-order drug release. The cellular uptake and cytotoxicity studies of these NPs in different human cancer lines, namely, human colorectal carcinoma cell line HCT116 and human breast cancer cell line MCF-7 demonstrated dose dependent cytotoxicity. Interestingly, both NPs showed CD44 dependent cellular uptake with the CS DOX NP displaying higher dose-dependent cytotoxicity than the HA DOX NP in different mammalian cells tested. Immunological evaluation of these nanocarriers in an ex vivo human whole blood model revealed that unlike unmodified polymers, the HA NP and CS NP surprisingly showed platelet aggregation and thrombin antithrombin complex formation at high concentrations (0.8 mg/mL). We also observed a clear difference in early- and late-stage complement activation (C3a and sC5b-9) with CS and CS NP triggering significant complement activation at high concentrations (0.08-0.8 mg/mL), unlike HA and HA NP. These results offer new insight into designing glycosaminoglycan-based NPs and understanding their hematological responses and targeting ability.

Keywords

  • Hyaluronic acid, chondroitin sulfate, nanoparticles, cancer, immune activation, drug delivery, POLYETHYLENE-GLYCOL, MOLECULAR-WEIGHT, PRODRUG APPROACH, DOXORUBICIN, ADRIAMYCIN, DELIVERY, THERAPY, RELEASE, DRUG, PACLITAXEL

Publication forum classification

Field of science, Statistics Finland